Access the full text.
Sign up today, get DeepDyve free for 14 days.
E. Thompson, J. Taube, Rebecca Asch-Kendrick, A. Ogurtsova, Haiying Xu, Rajni Sharma, A. Meeker, P. Argani, L. Emens, A. Cimino-Mathews (2017)
PD-L1 expression and the immune microenvironment in primary invasive lobular carcinomas of the breastModern Pathology, 30
V. Cocquyt, Phillip Blondeel, Herman Depypere, M. Praet, V. Schelfhout, O. Silva, J. Hurley, R. Serreyn, Kristof Daems, S. Belle (2003)
Different responses to preoperative chemotherapy for invasive lobular and invasive ductal breast carcinoma.European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology, 29 4
G. Thwaites (2002)
The Diagnosis and Management of Tuberculous MeningitisPractical Neurology, 2
E. Rakha, Arjun Patel, D. Powe, A. Benhasouna, A. Green, Maryou Lambros, J. Reis-Filho, I. Ellis (2010)
Clinical and Biological Significance of E-cadherin Protein Expression in Invasive Lobular Carcinoma of the BreastThe American Journal of Surgical Pathology, 34
J. Warneke, R. Berger, Cynthia Johnson, Dino Stea, H. Villar (1996)
Lumpectomy and radiation treatment for invasive lobular carcinoma of the breast.American journal of surgery, 172 5
I. Bajrami, Rebecca Marlow, M. Ven, R. Brough, H. Pemberton, J. Frankum, F. Song, Rumana Rafiq, A. Konde, Dragomir Krastev, Malini Menon, James Campbell, Aditi Gulati, Rahul Kumar, S. Pettitt, Mark Gurden, M. Cardeñosa, I. Chong, P. Gazinska, Fredrik Wållberg, E. Sawyer, L. Martin, M. Dowsett, S. Linardopoulos, R. Natrajan, Colm Ryan, P. Derksen, J. Jonkers, A. Tutt, A. Ashworth, C. Lord (2018)
E-Cadherin/ROS1 Inhibitor Synthetic Lethality in Breast Cancer.Cancer discovery, 8 4
D. Butler, M. Rosa (2013)
Pleomorphic lobular carcinoma of the breast: a morphologically and clinically distinct variant of lobular carcinoma.Archives of pathology & laboratory medicine, 137 11
(2017)
Assessing efficacy of carboplatin and atezolizumab in metastatic lobular breast cancer Netherlands: National Library of Medicine
Y. Adachi, J. Ishiguro, H. Kotani, T. Hisada, M. Ichikawa, Naomi Gondo, A. Yoshimura, N. Kondo, M. Hattori, M. Sawaki, T. Fujita, T. Kikumori, Y. Yatabe, Y. Kodera, H. Iwata (2016)
Comparison of clinical outcomes between luminal invasive ductal carcinoma and luminal invasive lobular carcinomaBMC Cancer, 16
S. Johnston, K. Cheung (2018)
Endocrine Therapy for Breast Cancer: A Model of Hormonal ManipulationOncology and Therapy, 6
Tian Du, Li Zhu, K. Levine, Nilgun Tasdemir, Adrian Lee, D. Vignali, B. Houten, G. Tseng, S. Oesterreich (2018)
Invasive lobular and ductal breast carcinoma differ in immune response, protein translation efficiency and metabolismScientific Reports, 8
Keren Merenbakh-Lamin, N. Ben-Baruch, A. Yeheskel, A. Dvir, L. Soussan-Gutman, R. Jeselsohn, R. Yelensky, Myles Brown, V. Miller, D. Sarid, S. Rizel, B. Klein, T. Rubinek, I. Wolf (2013)
D538G mutation in estrogen receptor-α: A novel mechanism for acquired endocrine resistance in breast cancer.Cancer research, 73 23
J. Fodor, T. Major, J. Tóth, Z. Sulyok, C. Polgár (2011)
Comparison of mastectomy with breast-conserving surgery in invasive lobular carcinoma: 15-Year results.Reports of practical oncology and radiotherapy : journal of Greatpoland Cancer Center in Poznan and Polish Society of Radiation Oncology, 16 6
Christopher Li, B. Anderson, P. Porter, S. Holt, J. Daling, R. Moe (2000)
Changing incidence rate of invasive lobular breast carcinoma among older womenCancer, 88
G. Arpino, V. Bardou, G. Clark, R. Elledge (2004)
Infiltrating lobular carcinoma of the breast: tumor characteristics and clinical outcomeBreast Cancer Research, 6
Jessica Robinson, Kelly Holmes, J. Carroll (2012)
FOXA1 mutations in hormone-dependent cancersFrontiers in Oncology, 3
Sung Kim, E. Cha, C. Park, B. Kang, I. Whang, A. Lee, B. Song, Jeong-Hee Park (2011)
Imaging features of invasive lobular carcinoma: comparison with invasive ductal carcinomaJapanese Journal of Radiology, 29
E. Rakha, M. El-Sayed, D. Powe, A. Green, H. Habashy, M. Grainge, J. Robertson, R. Blamey, J. Gee, R. Nicholson, Andrew Lee, I. Ellis (2008)
Invasive lobular carcinoma of the breast: response to hormonal therapy and outcomes.European journal of cancer, 44 1
J. Dixon, L. Renshaw, J. Dixon, J. Thomas (2011)
Invasive lobular carcinoma: response to neoadjuvant letrozole therapyBreast Cancer Research and Treatment, 130
Christopher Li, J. Daling (2007)
Changes in Breast Cancer Incidence Rates in the United States by Histologic Subtype and Race/Ethnicity, 1995 to 2004Cancer Epidemiology Biomarkers & Prevention, 16
S. Johnston, J. Carroll (2015)
Transcription factors and chromatin proteins as therapeutic targets in cancer.Biochimica et biophysica acta, 1855 2
Antoni Hurtado, Kelly Holmes, C. Ross-Innes, Dominic Schmidt, J. Carroll (2010)
FOXA1 is a critical determinant of Estrogen Receptor function and endocrine responseNature genetics, 43
M. Tubiana‐Hulin, D. Stevens, S. Lasry, J. Guinebretière, L. Bouita, C. Cohen-Solal, P. Chérel, J. Rouëssé (2006)
Response to neoadjuvant chemotherapy in lobular and ductal breast carcinomas: a retrospective study on 860 patients from one institution.Annals of oncology : official journal of the European Society for Medical Oncology, 17 8
V. Theodorou, R. Stark, S. Menon, J. Carroll (2013)
GATA3 acts upstream of FOXA1 in mediating ESR1 binding by shaping enhancer accessibilityGenome Research, 23
H. Nakshatri, S. Badve (2007)
FOXA1 as a therapeutic target for breast cancerExpert Opinion on Therapeutic Targets, 11
S. Droufakou, V. Deshmane, R. Roylance, A. Hanby, I. Tomlinson, I. Hart (2001)
Multiple ways of silencing E‐cadherin gene expression in lobular carcinoma of the breastInternational Journal of Cancer, 92
J. Carroll, X. Liu, A. Brodsky, Wei Li, Clifford Meyer, A. Szary, J. Eeckhoute, W. Shao, E. Hestermann, T. Geistlinger, E. Fox, P. Silver, Myles Brown (2005)
Chromosome-Wide Mapping of Estrogen Receptor Binding Reveals Long-Range Regulation Requiring the Forkhead Protein FoxA1Cell, 122
Joshua McMichael, L. Fulton, D. Dooling, Li Ding, R. Elaine, Mardis, R. Wilson, Miruna, Balasundaram, R. Carlsen, Candace Carter, Andy, M Chu, E. Chuah, Noreen Dhalla, Ranabir, Guin, Carrie Hirst, M. Hirst, R. Holt, D. Lee, Michael, Mayo, Richard Moore, A. Mungall, E. Pleasance, A. GordonRobertson, J. Schein, A. Shafiei, Payal Sipahimalani, Jared Slobodan, Yongjun Zhao, I. Birol, Steven Jones, R. Onofrio, S. Carter, S. Schumacher, B. Tabak, Bryan Hernandez, R. Beroukhim, W. Winckler, S. Gabriel, A. Prat, Grace Silva, Jerry Usary, Douglas Voet, N. Gehlenborg, Mike Lawrence, Lihua, Zou, Pei Lin, R. Jing, JuokCho, Raktim, Sinha, R. Park, Marc-Danie Nazaire, James Robinson, Helga, Thorvaldsdottir, J. Mesirov, Peter Park, L. Chin, R. Kreisberg, A. Jacobsen, Rileen Sinha, B. Reva, R. Shen, B. Taylor, Tod Casasent, A. Unruh, Joshua Stuart, Jingchun Zhu, Chris Szeto, G. Scott, C. Yau, Evan, O. Paull, Daniel Carlin, Artem Sokolov, J. Thusberg, S. Mooney, Jay Bowen, N. Ramirez, D. Aaron, Black, R. Pyatt, P. White, E. Zmuda, J. Frick, M. Tara, Lichtenberg, Robin Brookens, Myra George, Mark Gerken, A. Hollie, Harper, K. Leraas, Teresa Tabler (2013)
Comprehensive molecular portraits of human breast tumoursYearbook of Pathology and Laboratory Medicine, 2013
Man-Tat Lau, C. Klausen, Peter Leung (2011)
E-cadherin inhibits tumor cell growth by suppressing PI3K/Akt signaling via β-catenin-Egr1-mediated PTEN expressionOncogene, 30
V. Valero (2002)
Primary chemotherapy with docetaxel for the management of breast cancer.Oncology, 16 6 Suppl 6
C. Perou, T. Sørlie, M. Eisen, M. Rijn, S. Jeffrey, Christian Rees, J. Pollack, D. Ross, H. Johnsen, L. Akslen, Ø. Fluge, Alexander Pergamenschikov, Cheryl Williams, Shirley Zhu, P. Lønning, A. Børresen-Dale, P. Brown, D. Botstein (2000)
Molecular portraits of human breast tumoursNature, 406
L. Diepenmaat, M. Sangen, L. Poll-Franse, M. Beek, C. Berlo, E. Luiten, G. Nieuwenhuijzen, A. Voogd (2009)
The impact of postmastectomy radiotherapy on local control in patients with invasive lobular breast cancer.Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology, 91 1
S. Stecklein, Xinglei Shen, M. Mitchell (2016)
Post-Mastectomy Radiation Therapy for Invasive Lobular Carcinoma: A Comparative Utilization and Outcomes Study.Clinical breast cancer, 16 4
V. Martínez, J. Azzopardi (1979)
Invasive lobular carcinoma of the breast: incidence and variantsHistopathology, 3
M. Colleoni, N. Rotmensz, P. Maisonneuve, M. Mastropasqua, M. Mastropasqua, A. Luini, P. Veronesi, M. Intra, E. Montagna, G. Cancello, A. Cardillo, M. Mazza, G. Perri, M. Iorfida, G. Pruneri, A. Goldhirsch, G. Viale (2012)
Outcome of special types of luminal breast cancer.Annals of oncology : official journal of the European Society for Medical Oncology, 23 6
N. Wasif, M. Maggard, C. Ko, A. Giuliano (2010)
Invasive Lobular vs. Ductal Breast Cancer: A Stage-Matched Comparison of OutcomesAnnals of Surgical Oncology, 17
P. Newcomb, L. Titus-Ernstoff, K. Egan, A. Trentham-Dietz, J. Baron, B. Storer, W. Willett, M. Stampfer (2002)
Postmenopausal estrogen and progestin use in relation to breast cancer risk.Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology, 11 7
A. Mathew, P. Rajagopal, V. Villgran, G. Sandhu, R. Jankowitz, M. Jacob, M. Rosenzweig, S. Oesterreich, A. Brufsky (2017)
Distinct Pattern of Metastases in Patients with Invasive Lobular Carcinoma of the BreastGeburtshilfe und Frauenheilkunde, 77
N. Biglia, L. Mariani, L. Sgrò, P. Mininanni, Giulia Moggio, P. Sismondi (2007)
Increased incidence of lobular breast cancer in women treated with hormone replacement therapy: implications for diagnosis, surgical and medical treatment.Endocrine-related cancer, 14 3
Christopher Li, B. Anderson, J. Daling, R. Moe (2003)
Trends in incidence rates of invasive lobular and ductal breast carcinoma.JAMA, 289 11
V. Valero, A. Buzdar, M. Mcneese, E. Singletary, G. Hortobagyi (2002)
Primary chemotherapy in the treatment of breast cancer: the University of Texas M. D. Anderson Cancer Center experience.Clinical breast cancer, 3 Suppl 2
(ClinicalTrials.gov. Endocrine response in women with invasive lobular breast cancer United States: National Library of Medicine; 2014 [Clinical trial]. https://clinicaltrials.gov/ct2/show/NCT02206984. Accessed Nov 2019)
ClinicalTrials.gov. Endocrine response in women with invasive lobular breast cancer United States: National Library of Medicine; 2014 [Clinical trial]. https://clinicaltrials.gov/ct2/show/NCT02206984. Accessed Nov 2019ClinicalTrials.gov. Endocrine response in women with invasive lobular breast cancer United States: National Library of Medicine; 2014 [Clinical trial]. https://clinicaltrials.gov/ct2/show/NCT02206984. Accessed Nov 2019, ClinicalTrials.gov. Endocrine response in women with invasive lobular breast cancer United States: National Library of Medicine; 2014 [Clinical trial]. https://clinicaltrials.gov/ct2/show/NCT02206984. Accessed Nov 2019
Shunqiang Li, D. Shen, J. Shao, R. Crowder, Wenbin Liu, A. Prat, Xiaping He, Shuying Liu, J. Hoog, Charles Lu, L. Ding, O. Griffith, Christopher Miller, David Larson, R. Fulton, M. Harrison, Thomas Mooney, Joshua McMichael, Jingqin Luo, Y. Tao, R. Gonçalves, Christopher Schlosberg, J. Hiken, L. Saied, C. Sánchez, T. Giuntoli, Caroline Bumb, C. Cooper, R. Kitchens, A. Lin, C. Phommaly, S. Davies, Jin Zhang, M. Kavuri, D. McEachern, Yi Dong, Cynthia Ma, T. Pluard, M. Naughton, R. Bose, R. Suresh, R. McDowell, L. Michel, R. Aft, W. Gillanders, K. Deschryver, R. Wilson, Shaomeng Wang, G. Mills, A. González-Angulo, J. Edwards, C. Maher, C. Perou, E. Mardis, M. Ellis (2013)
Endocrine-therapy-resistant ESR1 variants revealed by genomic characterization of breast-cancer-derived xenografts.Cell reports, 4 6
D. Dabbs, Malathy Kaplai, M. Chivukula, A. Kanbour, A. Kanbour‐Shakir, G. Carter (2007)
The Spectrum of Morphomolecular Abnormalities of the E-Cadherin/Catenin Complex in Pleomorphic Lobular Carcinoma of the BreastApplied Immunohistochemistry & Molecular Morphology, 15
(ClinicalTrials.gov. ROS Targeting with crizotinib in advanced E-cadherin negative, ER positive lobular breast cancer or diffuse gastric cancer study United States: National Library of Medicine. https://clinicaltrials.gov/ct2/show/NCT03620643.)
ClinicalTrials.gov. ROS Targeting with crizotinib in advanced E-cadherin negative, ER positive lobular breast cancer or diffuse gastric cancer study United States: National Library of Medicine. https://clinicaltrials.gov/ct2/show/NCT03620643.ClinicalTrials.gov. ROS Targeting with crizotinib in advanced E-cadherin negative, ER positive lobular breast cancer or diffuse gastric cancer study United States: National Library of Medicine. https://clinicaltrials.gov/ct2/show/NCT03620643., ClinicalTrials.gov. ROS Targeting with crizotinib in advanced E-cadherin negative, ER positive lobular breast cancer or diffuse gastric cancer study United States: National Library of Medicine. https://clinicaltrials.gov/ct2/show/NCT03620643.
L. Silva, S. Parry, L. Reid, P. Keith, N. Waddell, M. Kossai, C. Clarke, S. Lakhani, P. Simpson (2008)
Aberrant Expression of E-cadherin in Lobular Carcinomas of the BreastThe American Journal of Surgical Pathology, 32
(2020)
National Library of Medicine; 2017
Weiyi Toy, Yang Shen, H. Won, B. Green, R. Sakr, Marie Will, Zhiqiang Li, K. Gala, S. Fanning, T. King, C. Hudis, David Chen, T. Taran, G. Hortobagyi, G. Greene, M. Berger, J. Baselga, S. Chandarlapaty (2013)
ESR1 ligand binding domain mutations in hormone-resistant breast cancerNature genetics, 45
T. Nagao, T. Kinoshita, T. Hojo, H. Tsuda, K. Tamura, Y. Fujiwara (2012)
The differences in the histological types of breast cancer and the response to neoadjuvant chemotherapy: the relationship between the outcome and the clinicopathological characteristics.Breast, 21 3
C. Desmedt, Julien Pingitore, F. Rothé, C. Marchiò, F. Clatot, G. Rouas, F. Richard, F. Bertucci, O. Mariani, C. Galant, C. Fribbens, B. O’Leary, G. Eynden, R. Salgado, N. Turner, M. Piccart, A. Vincent-Salomon, G. Pruneri, D. Larsimont, C. Sotiriou (2019)
ESR1 mutations in metastatic lobular breast cancer patientsNPJ Breast Cancer, 5
(2015)
Targeting FoxA1 in estrogen receptor-positive breast cancer: biological characterization of kinase regulatorsCancer Res, 76
M. Helvie, C. Paramagul, H. Oberman, D. Adler (1993)
Invasive Lobular Carcinoma Imaging Features and Clinical DetectionInvestigative Radiology, 28
R. Butler, L. Venta, E. Wiley, R. Ellis, P. Dempsey, E. Rubin (1999)
Sonographic evaluation of infiltrating lobular carcinoma.AJR. American journal of roentgenology, 172 2
S. Barker, Eileen Anderson, R. Mullen (2019)
Magnetic resonance imaging for invasive lobular carcinoma: is it worth it?Gland surgery, 8 3
N. Biglia, F. Maggiorotto, V. Liberale, V. Bounous, L. Sgrò, S. Pecchio, M. D'Alonzo, R. Ponzone (2013)
Clinical-pathologic features, long term-outcome and surgical treatment in a large series of patients with invasive lobular carcinoma (ILC) and invasive ductal carcinoma (IDC).European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology, 39 5
Eleonora Brunello, M. Brunelli, E. Manfrin, A. Nottegar, S. Bersani, M. Vergine, A. Molino, E. Fiorio, M. Chilosi, S. Gobbo, G. Martignoni, F. Bonetti (2012)
Classical lobular breast carcinoma consistently lacks topoisomerase‐IIα gene amplification: implications for the tailored use of anthracycline‐based chemotherapiesHistopathology, 60
S. Lakhani (2012)
WHO classification of tumours of the breast
L. Braunstein, J. Brock, Yu‐Hui Chen, L. Truong, A. Russo, Nils Arvold, J. Harris (2015)
Invasive lobular carcinoma of the breast: local recurrence after breast-conserving therapy by subtype approximation and surgical marginBreast Cancer Research and Treatment, 149
S. Johnston, Kelly Holmes, J. Carroll (2016)
Abstract 2906: Targeting FoxA1 in estrogen receptor-positive breast cancer: biological characterization of kinase regulatorsCancer Research, 76
W. Birchmeier, J. Behrens (1994)
Cadherin expression in carcinomas: role in the formation of cell junctions and the prevention of invasiveness.Biochimica et biophysica acta, 1198 1
S. Im, Yen-Shen Lu, A. Bardia, N. Harbeck, M. Colleoni, F. Franke, L. Chow, J. Sohn, K. Lee, S. Campos-Gómez, Rafael Villanueva-Vázquez, K. Jung, A. Chakravartty, G. Hughes, I. Gounaris, Karen Rodriguez-Lorenc, T. Taran, S. Hurvitz, D. Tripathy (2019)
Overall Survival with Ribociclib plus Endocrine Therapy in Breast Cancer.The New England journal of medicine
G. Ciriello, Michael Gatza, Andrew Beck, M. Wilkerson, S. Rhie, A. Pastore, Hailei Zhang, M. McLellan, C. Yau, C. Kandoth, R. Bowlby, Hui Shen, S. Hayat, R. Fieldhouse, S. Lester, G. Tse, R. Factor, L. Collins, K. Allison, Yunni-Yi Chen, K. Jensen, N. Johnson, S. Oesterreich, G. Mills, A. Cherniack, Gordon Robertson, C. Benz, C. Sander, P. Laird, K. Hoadley, T. King, C. Perou, R. Akbani, J. Auman, M. Balasundaram, S. Balu, T. Barr, A. Beck, S. Benz, Mario Berrios, R. Beroukhim, T. Bodenheimer, L. Boice, M. Bootwalla, Jay Bowen, Denise Brooks, L. Chin, Juok Cho, Sudha Chudamani, Tanja Davidsen, John Demchok, J. Dennison, L. Ding, Ina Felau, M. Ferguson, S. Frazer, S. Gabriel, Jianjiong Gao, J. Gastier-Foster, N. Gehlenborg, M. Gerken, G. Getz, W. Gibson, D. Hayes, David Heiman, Andrea Holbrook, R. Holt, A. Hoyle, Hai Hu, Meijuan Huang, C. Hutter, E. Hwang, S. Jefferys, Steven Jones, Z. Ju, Jaegil Kim, Phillip Lai, M. Lawrence, K. Leraas, T. Lichtenberg, Pei Lin, Shiyun Ling, Jia Liu, Wenbin Liu, Laxmi Lolla, Yiling Lu, Yussanne Ma, D. Maglinte, E. Mardis, J. Marks, M. Marra, Cynthia McAllister, S. Meng, M. Meyerson, Richard Moore, Lisle Mose, A. Mungall, Bradley Murray, R. Naresh, M. Noble, O. Olopade, J. Parker, T. Pihl, G. Saksena, S. Schumacher, K. Shaw, N. Ramirez, W. Rathmell, J. Roach, A. Robertson, J. Schein, N. Schultz, Margi Sheth, Yan Shi, J. Shih, C. Shelley, C. Shriver, J. Simons, H. Sofia, Matthew Soloway, C. Sougnez, Charlie Sun, R. Tarnuzzer, D. Tiezzi, D. Berg, Douglas Voet, Yunhu Wan, Zhining Wang, J. Weinstein, D. Weisenberger, R. Wilson, L. Wise, M. Wiznerowicz, Junyuan Wu, Ye Wu, Liming Yang, Travis Zack, J. Zenklusen, J. Zhang, E. Zmuda (2015)
Comprehensive Molecular Portraits of Invasive Lobular Breast CancerCell, 163
D. Dabbs, R. Bhargava, M. Chivukula (2007)
Lobular Versus Ductal Breast Neoplasms: The Diagnostic Utility of P120 CateninThe American Journal of Surgical Pathology, 31
C. Desmedt, R. Salgado, M. Fornili, G. Pruneri, G. Eynden, G. Zoppoli, F. Rothé, L. Buisseret, S. Garaud, K. Willard-Gallo, David Brown, Y. Bareche, G. Rouas, C. Galant, F. Bertucci, S. Loi, G. Viale, A. Leo, A. Green, I. Ellis, E. Rakha, D. Larsimont, E. Biganzoli, C. Sotiriou (2018)
Immune Infiltration in Invasive Lobular Breast CancerJNCI Journal of the National Cancer Institute, 110
A. Reed, Jamie Kutasovic, S. Lakhani, P. Simpson (2015)
Invasive lobular carcinoma of the breast: morphology, biomarkers and ’omicsBreast Cancer Research : BCR, 17
D. Robinson, Yi-Mi Wu, Pankaj Vats, Fengyun Su, R. Lonigro, Xuhong Cao, Shanker Kalyana-Sundaram, Rui Wang, Yu Ning, L. Hodges, Amy Gursky, J. Siddiqui, S. Tomlins, S. Roychowdhury, K. Pienta, Scott Kim, J. Roberts, J. Rae, C. Poznak, D. Hayes, R. Chugh, L. Kunju, M. Talpaz, A. Schott, A. Chinnaiyan (2013)
Activating ESR1 mutations in hormone-resistant metastatic breast cancerNature Genetics, 45
H. Sinn, H. Kreipe (2013)
A Brief Overview of the WHO Classification of Breast Tumors, 4th Edition, Focusing on Issues and Updates from the 3rd EditionBreast Care, 8
January Lopez, L. Bassett (2009)
Invasive lobular carcinoma of the breast: spectrum of mammographic, US, and MR imaging findings.Radiographics : a review publication of the Radiological Society of North America, Inc, 29 1
D. Koboldt, R. Fulton, M. McLellan, Heather Schmidt, Joelle Kalicki-Veizer, Joshua McMichael, L. Fulton, D. Dooling, L. Ding, E. Mardis, R. Wilson, Adrian Ally, M. Balasundaram, Y. Butterfield, R. Carlsen, Candace Carter, Andy Chu, E. Chuah, Hye-Jung Chun, R. Coope, Noreen Dhalla, R. Guin, Carrie Hirst, M. Hirst, R. Holt, Darlene Lee, H. Li, Michael Mayo, Richard Moore, A. Mungall, E. Pleasance, A. Robertson, J. Schein, A. Shafiei, Payal Sipahimalani, Jared Slobodan, D. Stoll, Angela Tam, N. Thiessen, R. Varhol, N. Wye, Thomas Zeng, Yongjun Zhao, I. Birol, Steven Jones, M. Marra, A. Cherniack, G. Saksena, R. Onofrio, Nam Pho, S. Carter, S. Schumacher, B. Tabak, Bryan Hernandez, Jeff Gentry, Huy Nguyen, A. Crenshaw, K. Ardlie, R. Beroukhim, W. Winckler, G. Getz, S. Gabriel, M. Meyerson, L. Chin, R. Kucherlapati, K. Hoadley, J. Auman, C. Fan, Yidi Turman, Yan Shi, Ling Li, M. Topal, Xiaping He, H. Chao, A. Prat, Grace Silva, M. Iglesia, Wei Zhao, Jerry Usary, J. Berg, Michael Adams, J. Booker, Junyuan Wu, Anisha Gulabani, T. Bodenheimer, A. Hoyle, J. Simons, Matthew Soloway, Lisle Mose, S. Jefferys, S. Balu, J. Parker, D. Hayes, C. Perou, Simeen Malik, S. Mahurkar, Hui Shen, D. Weisenberger, T. Triche, Phillip Lai, M. Bootwalla, D. Maglinte, B. Berman, D. Berg, S. Baylin, P. Laird, C. Creighton, L. Donehower, M. Noble, Douglas Voet, N. Gehlenborg, D. Cara, Juinhua Zhang, Hailei Zhang, Chang-Jiun Wu, Spring Liu, M. Lawrence, L. Zou, A. Sivachenko, Pei Lin, P. Stojanov, R. Jing, Juok Cho, Raktim Sinha, R. Park, Marc-Danie Nazaire, James Robinson, H. Thorvaldsdóttir, J. Mesirov, P. Park, Sheila Reynolds, R. Kreisberg, Brady Bernard, Ryan Bressler, Timo Erkkilä, Jake Lin, V. Thorsson, Wei Zhang, I. Shmulevich, G. Ciriello, Nils Weinhold, N. Schultz, Jianjiong Gao, E. Cerami, Benjamin Gross, A. Jacobsen, Rileen Sinha, B. Aksoy, Yevgeniy Antipin, B. Reva, R. Shen, B. Taylor, M. Ladanyi, C. Sander, Pavana Anur, P. Spellman, Yiling Lu, Wenbin Liu, R. Verhaak, G. Mills, R. Akbani, Nianxiang Zhang, B. Broom, Tod Casasent, Chris Wakefield, A. Unruh, K. Baggerly, K. Coombes, J. Weinstein, D. Haussler, C. Benz, Joshua Stuart, S. Benz, Jingchun Zhu, C. Szeto, G. Scott, C. Yau, Evan Paull, Daniel Carlin, Christopher Wong, Artem Sokolov, J. Thusberg, S. Mooney, S. Ng, Theodore Goldstein, K. Ellrott, Mia Grifford, C. Wilks, Singer Ma, Brian Craft, Chunhua Yan, Ying Hu, D. Meerzaman, J. Gastier-Foster, Jay Bowen, N. Ramirez, Aaron Black, R. Pyatt, P. White, E. Zmuda, J. Frick, T. Lichtenberg, Robin Brookens, Myra George, M. Gerken, H. Harper, K. Leraas, L. Wise, Teresa Tabler, Cynthia McAllister, T. Barr, Melissa Hart-Kothari, Katherine Tarvin, Charles Saller, G. Sandusky, Colleen Mitchell, M. Iacocca, Jennifer Brown, B. Rabeno, Christine Czerwinski, N. Petrelli, Oleg Dolzhansky, M. Abramov, Olga Voronina, O. Potapova, J. Marks, W. Suchorska, D. Murawa, W. Kycler, Matthew Ibbs, Konstanty Korski, A. Spychała, P. Murawa, Jacek Brzeziński, Hanna Perz, Radoslaw Łaźniak, M. Teresiak, Honorata Tatka, E. Leporowska, M. Bogusz-Czerniewicz, J. Malicki, A. Mackiewicz, M. Wiznerowicz, X. Le, B. Kohl, N. Tien, Richard Thorp, N. Bang, H. Sussman, Bui Phu, R. Hajek, N. Hung, H. Thang, K. Khan, R. Penny, D. Mallery, Erin Curley, C. Shelton, P. Yena, J. Ingle, F. Couch, W. Lingle, T. King, A. González-Angulo, Mary Dyer, Shuying Liu, Xiaolong Meng, Modesto Patangan, F. Waldman, H. Stoppler, W. Rathmell, L. Thorne, Meijuan Huang, L. Boice, Ashley Hill, C. Morrison, Carmelo Gaudioso, W. Bshara, K. Daily, Sophie Egea, M. Pegram, C. Gomez-Fernandez, R. Dhir, R. Bhargava, A. Brufsky, C. Shriver, J. Hooke, J. Campbell, R. Mural, Hai Hu, S. Somiari, C. Larson, B. Deyarmin, L. Kvecher, A. Kovatich, M. Ellis, T. Stricker, K. White, O. Olopade, C. Luo, Y. Chen, R. Bose, Li-Wei Chang, Andrew Beck, T. Pihl, M. Jensen, R. Sfeir, A. Kahn, A. Chu, Prachi Kothiyal, Zhining Wang, E. Snyder, J. Pontius, Brenda Ayala, M. Backus, Jessica Walton, J. Baboud, D. Berton, M. Nicholls, Deepak Srinivasan, R. Raman, Stanley Girshik, Peter Kigonya, S. Alonso, Rashmi Sanbhadti, S. Barletta, D. Pot, Margi Sheth, John Demchok, K. Shaw, Liming Yang, G. Eley, M. Ferguson, R. Tarnuzzer, J. Zhang, Laura Dillon, K. Buetow, P. Fielding, B. Ozenberger, M. Guyer, H. Sofia, Jacqueline Palchik (2012)
Comprehensive molecular portraits of human breast tumorsNature, 490
B. Pestalozzi, D. Zahrieh, E. Mallon, B. Gusterson, K. Price, R. Gelber, S. Holmberg, J. Lindtner, R. Snyder, B. Thürlimann, E. Murray, G. Viale, M. Castiglione‐Gertsch, A. Coates, A. Goldhirsch (2008)
Distinct clinical and prognostic features of infiltrating lobular carcinoma of the breast: combined results of 15 International Breast Cancer Study Group clinical trials.Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 26 18
G. Handschuh, S. Candidus, B. Luber, U. Reich, C. Schott, Sandra Oswald, Helma Becke, P. Hutzler, W. Birchmeier, H. Höfler, K. Becker (1999)
Tumour-associated E-cadherin mutations alter cellular morphology, decrease cellular adhesion and increase cellular motilityOncogene, 18
(ClinicalTrials.gov. Palbociclib and endocrine therapy for lobular breast cancer United States: National Library of Medicine; 2016. https://clinicaltrials.gov/ct2/show/NCT02764541.)
ClinicalTrials.gov. Palbociclib and endocrine therapy for lobular breast cancer United States: National Library of Medicine; 2016. https://clinicaltrials.gov/ct2/show/NCT02764541.ClinicalTrials.gov. Palbociclib and endocrine therapy for lobular breast cancer United States: National Library of Medicine; 2016. https://clinicaltrials.gov/ct2/show/NCT02764541., ClinicalTrials.gov. Palbociclib and endocrine therapy for lobular breast cancer United States: National Library of Medicine; 2016. https://clinicaltrials.gov/ct2/show/NCT02764541.
R. Akbani, P. Ng, H. Werner, Maria Shahmoradgoli, Fan Zhang, Z. Ju, Wenbin Liu, Ji-Yeon Yang, K. Yoshihara, Jun Li, Shiyun Ling, E. Seviour, Prahlad Ram, J. Minna, L. Diao, P. Tong, J. Heymach, S. Hill, F. Dondelinger, N. Städler, L. Byers, F. Meric-Bernstam, J. Weinstein, B. Broom, R. Verhaak, Han Liang, S. Mukherjee, Yiling Lu, G. Mills (2014)
A pan-cancer proteomic perspective on The Cancer Genome AtlasNature communications, 5
L. Newcomer, P. Newcomb, J. Potter, Y. Yasui, A. Trentham-Dietz, B. Storer, M. Longnecker, J. Baron, J. Daling (2003)
Postmenopausal hormone therapy and risk of breast cancer by histologic type (United States)Cancer Causes & Control, 14
G. Babiera, A. Lowy, B. Davidson, S. Singletary (1997)
The Role of Contralateral Prophylactic Mastectomy in Invasive Lobular CarcinomaThe Breast Journal, 3
Matthew Sikora, R. Jankowitz, D. Dabbs, S. Oesterreich (2013)
Invasive lobular carcinoma of the breast: Patient response to systemic endocrine therapy and hormone response in model systemsSteroids, 78
D. Sarrió, G. Moreno-Bueno, D. Hardisson, C. Sánchez-Estévez, Min Guo, J. Herman, C. Gamallo, M. Esteller, J. Palacios (2003)
Epigenetic and genetic alterations of APC and CDH1 genes in lobular breast cancer: Relationships with abnormal E‐cadherin and catenin expression and microsatellite instabilityInternational Journal of Cancer, 106
J. Kotsopoulos, Wendy Chen, Margaret Gates, S. Tworoger, S. Hankinson, B. Rosner (2010)
Risk factors for ductal and lobular breast cancer: results from the nurses' health studyBreast Cancer Research : BCR, 12
Matthew Sikora, K. Cooper, A. Bahreini, Soumya Luthra, Guoying Wang, U. Chandran, N. Davidson, D. Dabbs, A. Welm, S. Oesterreich (2014)
Invasive lobular carcinoma cell lines are characterized by unique estrogen-mediated gene expression patterns and altered tamoxifen response.Cancer research, 74 5
Matthew Sikora, B. Jacobsen, K. Levine, Jian Chen, N. Davidson, Adrian Lee, C. Alexander, S. Oesterreich (2016)
WNT4 mediates estrogen receptor signaling and endocrine resistance in invasive lobular carcinoma cell linesBreast Cancer Research : BCR, 18
A. Reed, Jamie Kutasovic, A. Vargas, J. Jayanthan, Amel Al-Murrani, L. Reid, R. Chambers, Leonard Silva, Lewis Melville, E. Evans, A. Porter, D. Papadimos, E. Thompson, S. Lakhani, P. Simpson (2016)
An epithelial to mesenchymal transition programme does not usually drive the phenotype of invasive lobular carcinomasThe Journal of Pathology, 238
O. Filho, A. Giobbie-Hurder, E. Mallon, B. Gusterson, G. Viale, E. Winer, B. Thürlimann, R. Gelber, M. Colleoni, B. Ejlertsen, M. Debled, K. Price, M. Regan, A. Coates, A. Goldhirsch (2015)
Relative Effectiveness of Letrozole Compared With Tamoxifen for Patients With Lobular Carcinoma in the BIG 1-98 Trial.Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 33 25
ROS Targeting with crizotinib in advanced E - cadherin negative , ER positive lobular breast cancer or diffuse gastric cancer study United States : National Library of Medicine
(ClinicalTrials.gov. Assessing efficacy of carboplatin and atezolizumab in metastatic lobular breast cancer Netherlands: National Library of Medicine; 2017. https://clinicaltrials.gov/ct2/show/NCT03147040.)
ClinicalTrials.gov. Assessing efficacy of carboplatin and atezolizumab in metastatic lobular breast cancer Netherlands: National Library of Medicine; 2017. https://clinicaltrials.gov/ct2/show/NCT03147040.ClinicalTrials.gov. Assessing efficacy of carboplatin and atezolizumab in metastatic lobular breast cancer Netherlands: National Library of Medicine; 2017. https://clinicaltrials.gov/ct2/show/NCT03147040., ClinicalTrials.gov. Assessing efficacy of carboplatin and atezolizumab in metastatic lobular breast cancer Netherlands: National Library of Medicine; 2017. https://clinicaltrials.gov/ct2/show/NCT03147040.
N. Turner, D. Slamon, J. Ro, I. Bondarenko, S. Im, N. Masuda, M. Colleoni, A. DeMichele, S. Loi, S. Verma, H. Iwata, N. Harbeck, S. Loibl, F. André, K. Theall, Xin Huang, C. Giorgetti, C. Bartlett, M. Cristofanilli (2018)
Overall Survival with Palbociclib and Fulvestrant in Advanced Breast CancerThe New England Journal of Medicine, 379
R. Schackmann, Miranda Amersfoort, Judith Haarhuis, E. Vlug, Vincentius Halim, J. Roodhart, J. Vermaat, E. Voest, P. Groep, P. Diest, J. Jonkers, P. Derksen (2011)
Cytosolic p120-catenin regulates growth of metastatic lobular carcinoma through Rock1-mediated anoikis resistance.The Journal of clinical investigation, 121 8
M. Christgen, D. Steinemann, E. Kühnle, F. Länger, O. Gluz, N. Harbeck, H. Kreipe (2016)
Lobular breast cancer: Clinical, molecular and morphological characteristics.Pathology, research and practice, 212 7
(National Institute for Health and Care Excellence, UK. Early and locally advanced breast cancer: diagnosis and management. 2018. Clinical Guideline NG101. Available online: https://www.nice.org.uk/guidance/ng101. Accessed Nov 2019)
National Institute for Health and Care Excellence, UK. Early and locally advanced breast cancer: diagnosis and management. 2018. Clinical Guideline NG101. Available online: https://www.nice.org.uk/guidance/ng101. Accessed Nov 2019National Institute for Health and Care Excellence, UK. Early and locally advanced breast cancer: diagnosis and management. 2018. Clinical Guideline NG101. Available online: https://www.nice.org.uk/guidance/ng101. Accessed Nov 2019, National Institute for Health and Care Excellence, UK. Early and locally advanced breast cancer: diagnosis and management. 2018. Clinical Guideline NG101. Available online: https://www.nice.org.uk/guidance/ng101. Accessed Nov 2019
M. Cristofanilli, A. González-Angulo, N. Sneige, S. Kau, K. Broglio, R. Theriault, V. Valero, A. Buzdar, H. Kuerer, T. Buchholz, G. Hortobagyi (2005)
Invasive lobular carcinoma classic type: response to primary chemotherapy and survival outcomes.Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 23 1
Invasive lobular carcinoma comprises 10–15% of all breast cancers and is increasingly recognised as a distinct and understudied disease compared with the predominant histological subtype, invasive ductal carcinoma. Hallmarks of invasive lobular carcinoma include E-cadherin loss, leading to discohesive morphology with cells proliferating in single-file strands and oestrogen receptor positivity, with favourable response to endocrine therapy. This review summarises the distinct histological and molecular features of invasive lobular carcinoma with focus on diagnostic challenges and the impact on surgical management and medical therapy. Emphasis is placed on recent advances in our understanding of the unique molecular biology of lobular breast cancer and how this is optimising our therapy approach in the clinic.
Oncology and Therapy – Springer Journals
Published: Jun 24, 2020
Read and print from thousands of top scholarly journals.
Already have an account? Log in
Bookmark this article. You can see your Bookmarks on your DeepDyve Library.
To save an article, log in first, or sign up for a DeepDyve account if you don’t already have one.
Copy and paste the desired citation format or use the link below to download a file formatted for EndNote
Access the full text.
Sign up today, get DeepDyve free for 14 days.
All DeepDyve websites use cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your cookie settings through your browser.